These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 11844688

  • 1. Di- and trisubstituted pyrazolo[1,5-a]pyridine derivatives: synthesis, dopamine receptor binding and ligand efficacy.
    Löber S, Aboul-Fadl T, Hübner H, Gmeiner P.
    Bioorg Med Chem Lett; 2002 Feb 25; 12(4):633-6. PubMed ID: 11844688
    [Abstract] [Full Text] [Related]

  • 2. Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).
    Löber S, Hübner H, Utz W, Gmeiner P.
    J Med Chem; 2001 Aug 16; 44(17):2691-4. PubMed ID: 11495580
    [Abstract] [Full Text] [Related]

  • 3. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
    Elsner J, Boeckler F, Heinemann FW, Hübner H, Gmeiner P.
    J Med Chem; 2005 Sep 08; 48(18):5771-9. PubMed ID: 16134944
    [Abstract] [Full Text] [Related]

  • 4. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH.
    J Med Chem; 2005 Feb 10; 48(3):839-48. PubMed ID: 15689168
    [Abstract] [Full Text] [Related]

  • 5. Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps.
    Löber S, Hübner H, Gmeiner P.
    Bioorg Med Chem Lett; 1999 Jan 04; 9(1):97-102. PubMed ID: 9990464
    [Abstract] [Full Text] [Related]

  • 6. Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure.
    Möller D, Banerjee A, Uzuneser TC, Skultety M, Huth T, Plouffe B, Hübner H, Alzheimer C, Friedland K, Müller CP, Bouvier M, Gmeiner P.
    J Med Chem; 2017 Apr 13; 60(7):2908-2929. PubMed ID: 28248104
    [Abstract] [Full Text] [Related]

  • 7. Fused azaindole derivatives: molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725.
    Löber S, Hübner H, Gmeiner P.
    Bioorg Med Chem Lett; 2002 Sep 02; 12(17):2377-80. PubMed ID: 12161137
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.
    Peng X, Wang Q, Mishra Y, Xu J, Reichert DE, Malik M, Taylor M, Luedtke RR, Mach RH.
    Bioorg Med Chem Lett; 2015 Feb 01; 25(3):519-23. PubMed ID: 25556097
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists.
    Wang X, Bhatia PA, Daanen JF, Latsaw SP, Rohde J, Kolasa T, Hakeem AA, Matulenko MA, Nakane M, Uchic ME, Miller LN, Chang R, Moreland RB, Brioni JD, Stewart AO.
    Bioorg Med Chem; 2005 Aug 01; 13(15):4667-78. PubMed ID: 15896964
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
    Kung MP, Stevenson DA, Zhuang ZP, Vessotskie JM, Chumpradit S, Sun XM, Kung HF.
    Life Sci; 1997 Aug 01; 60(2):91-100. PubMed ID: 9000114
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of fluorine-substituted 1H-pyrrolo[2,3-b]pyridine derivatives for dopamine D4 receptor imaging.
    Oh SJ, Lee KC, Lee SY, Ryu EK, Saji H, Choe YS, Chi DY, Kim SE, Lee J, Kim BT.
    Bioorg Med Chem; 2004 Nov 01; 12(21):5505-13. PubMed ID: 15465327
    [Abstract] [Full Text] [Related]

  • 12. Cyanoindole derivatives as highly selective dopamine D(4) receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments.
    Hübner H, Kraxner J, Gmeiner P.
    J Med Chem; 2000 Nov 16; 43(23):4563-9. PubMed ID: 11087581
    [Abstract] [Full Text] [Related]

  • 13. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors.
    Newman-Tancredi A, Audinot-Bouchez V, Gobert A, Millan MJ.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):379-83. PubMed ID: 9042615
    [Abstract] [Full Text] [Related]

  • 14. 2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356.
    Bergauer M, Hübner H, Gmeiner P.
    Bioorg Med Chem Lett; 2002 Aug 05; 12(15):1937-40. PubMed ID: 12113813
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET.
    Prante O, Tietze R, Hocke C, Löber S, Hübner H, Kuwert T, Gmeiner P.
    J Med Chem; 2008 Mar 27; 51(6):1800-10. PubMed ID: 18307287
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analogues of FAUC 73 revealing new insights into the structural requirements of nonaromatic dopamine D3 receptor agonists.
    Lenz C, Boeckler F, Hübner H, Gmeiner P.
    Bioorg Med Chem; 2004 Jan 02; 12(1):113-7. PubMed ID: 14697776
    [Abstract] [Full Text] [Related]

  • 18. β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.
    Männel B, Hübner H, Möller D, Gmeiner P.
    Bioorg Med Chem; 2017 Oct 15; 25(20):5613-5628. PubMed ID: 28870802
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.